{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"34.020","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"299,807,117","primaryexch":"HKEX","ric":"1513.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":2.2395,"inline_upper_strike_price":"","sedol":"BJ34614","am":"32.38","iv":"","ew_strike":"","as":"33.720","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"33.700","registrar":"Tricor Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-26 10:38:37.0","lo52":"24.850","shares_issued_date":"25 Sep 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Zhu Baoguo","underlying_ric":"000513.SZ","hi52":"41.850","issuer_name":"Livzon Pharmaceutical Group Inc. - H Shares","h_share_flag":true,"ew_sub_per_from":"","div_yield":"3.56","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"33.300","mkt_cap":"10.10","f_aum_hkd":null,"ew_sub_per_to":"","ls":"33.700","nav_date":"","csic_classification":"Health Care","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-0.380","aum":"","issued_shares_class_B":null,"vo":"960.85","secondary_listing_flag":false,"listing_date":"16 Jan 2014","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Livzon Pharmaceutical Group Inc. - H Shares","nm_s":"LIVZON PHARMA","sym":"1513","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The Company's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The Company's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The Company mainly operates its businesses in the domestic and overseas markets.","op":"34.020","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Headquarter Building<br/>38 Chuangye North Road<br/>Jinwan District, Zhuhai<br/>Guangdong Province, PRC 519090","pc":"-1.12","days_to_expiry":null,"underlying_code":null,"pe":"14.22","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"34.080","isin":"CNE100001QV5","moneyness":""}},"qid":"1758890270834"}
